Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866987
Max Phase: Preclinical
Molecular Formula: C13H14ClN3O3
Molecular Weight: 295.73
Molecule Type: Unknown
Associated Items:
ID: ALA4866987
Max Phase: Preclinical
Molecular Formula: C13H14ClN3O3
Molecular Weight: 295.73
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncc([N+](=O)[O-])n1CCOCc1cccc(Cl)c1
Standard InChI: InChI=1S/C13H14ClN3O3/c1-10-15-8-13(17(18)19)16(10)5-6-20-9-11-3-2-4-12(14)7-11/h2-4,7-8H,5-6,9H2,1H3
Standard InChI Key: APOTUSGMZRAPHK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 295.73 | Molecular Weight (Monoisotopic): 295.0724 | AlogP: 2.97 | #Rotatable Bonds: 6 |
Polar Surface Area: 70.19 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.03 | CX LogP: 2.51 | CX LogD: 2.51 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.47 | Np Likeness Score: -2.12 |
1. Patel OPS, Jesumoroti OJ, Legoabe LJ, Beteck RM.. (2021) Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective., 210 [PMID:33234343] [10.1016/j.ejmech.2020.112994] |
Source(1):